|
|
||||||||
American Journal of Roentgenology, Vol 157, 59-65, Copyright © 1991 by American Roentgen Ray Society
ARTICLES |
EM Lautin, NJ Freeman, AH Schoenfeld, CW Bakal, N Haramati, AC Friedman, JL Lautin, S Braha, EG Kadish and N] Haramiti N$[corrected to Haramati
Department of Radiology, Montefiore Medical Center, Bronx, NY 10467.
Nephropathy is an established untoward event associated with intravascular administration of conventional high-osmolality contrast media (HOM). It has not been shown previously that lower-osmolality contrast media (LOM) are less nephrotoxic in a clinical setting. We evaluate the ability to replace HOM with LOM (in lower-extremity angiography) to reduce the incidence of nephropathy. We use multiple definitions for contrast-induced nephropathy (six different magnitudes of rise of serum levels of creatinine or blood urea nitrogen in various periods). The incidences of nephrotoxic effects with LOM vs HOM in patients with presumed risk factors, including preexisting renal insufficiency and diabetes, are evaluated also. When all patients are considered, the incidence of contrast-induced nephropathy for LOM vs HOM (defined as an increase in serum creatinine level greater than 0.3 mg/dl and greater than 20% on day 1, 2, or 3 and on day 5, 6, or 7, is 7% vs 26% (p = .001). When only patients with preangiography azotemia are considered, the incidence of contrast-induced nephropathy for LOM vs HOM is 10% vs 41% (p = .017); for diabetic patients, regardless of preangiography creatinine level, the incidence is 10% vs 31% (p = .012). Although contrast-induced nephropathy may develop even in a patient with no risk factors who receives LOM, LOM is associated with a decreased incidence of this condition, to various degrees, depending on the presence of risk factors.
This article has been cited by other articles:
![]() |
E. Ascher, A. P. Hingorani, and N. Marks Duplex-Guided Balloon Angioplasty of Lower Extremity Arteries Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2007; 19(1): 23 - 31. [Abstract] [PDF] |
||||
![]() |
E. Ascher, A. P. Hingorani, and N. Marks Duplex-Assisted Internal Carotid Artery Balloon Angioplasty and Stent Placement Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2007; 19(1): 41 - 47. [Abstract] [PDF] |
||||
![]() |
S.-H. Jo, T.-J. Youn, B.-K. Koo, J.-S. Park, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, G.-W. Joo, I.-H. Chae, D.-J. Choi, et al. Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study: A Randomized Controlled Trial J. Am. Coll. Cardiol., September 5, 2006; 48(5): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orlandini, S. Boini, S. Iochum-Duchamps, T. Batch, X. Zhu, and A. Blum Assessment of the use of a saline chaser to reduce the volume of contrast medium in abdominal CT. Am. J. Roentgenol., August 1, 2006; 187(2): 511 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Gleeson and S. Bulugahapitiya Contrast-Induced Nephropathy Am. J. Roentgenol., December 1, 2004; 183(6): 1673 - 1689. [Full Text] [PDF] |
||||
![]() |
P. Aspelin, P. Aubry, S.-G. Fransson, R. Strasser, R. Willenbrock, K. J. Berg, and the NEPHRIC Study Investigators Nephrotoxic Effects in High-Risk Patients Undergoing Angiography N. Engl. J. Med., February 6, 2003; 348(6): 491 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gruberg, G. S. Mintz, R. Mehran, G. Dangas, A. J. Lansky, K. M. Kent, A. D. Pichard, L. F. Satler, and M. B. Leon The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Tippins, W. E. Torres, B. R. Baumgartner, and D. A. Baumgarten Are Screening Serum Creatinine Levels Necessary prior to Outpatient CT Examinations? Radiology, August 1, 2000; 216(2): 481 - 484. [Abstract] [Full Text] |
||||
![]() |
L. A Sanchez and F. J Veith Diagnosis and treatment of chronic lower extremity ischemia Vascular Medicine, November 1, 1998; 3(4): 291 - 299. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |